the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
November 05, 2017 – The commercial names are creative, no doubt, and we like particularly “Black Gorilla”. However, time and time again, health authorities all over have to issue foreign product alerts, warning consumers, patients, and the public at large about …
Black Gorilla, Big N Hard, Rize N Shine, and the likes: Fraudulent health business Read more »
November 01, 2017 – According to the watch list of the American Food & Drug Administration (FDA) for drugs with possible safety issues from January to March 2016, the FDA was looking at the possible link between various drugs in the phosphodiesterase-5 …
Is there a risk of melanoma with erectile dysfunction drugs? Read more »
September 30, 2017 – Obeticholic acid (Ocaliva) was approved by the American Food & Drug Administration (FDA) in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adult patients with an inadequate response …
Obeticholic Acid (Ocaliva): Is there a serious drug safety problem? Read more »
May 17, 2017 – Following up on an earlier Drug Safety Communication from May 2016 and based on new data from two large clinical trials, the American Food & Drug Administration (FDA) has concluded that the type 2 diabetes medicines …
Risk of leg and foot amputations under Canagliflozin (Invokana, Invokamet) Read more »
April 23, 2017 – This is a Safety Announcement from April 20, 2017, by the American Food & Drug Administration (FDA) to the fact that FDA further restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in …
Living theragenomics: Dangers of codeine and tramadol medicines in children Read more »
March 27, 2017 – We all adore the beauty of women. Some women may feel that they need some help from medical practice to become the most beautiful. When it comes to corrective breast implants, the price may be very …
March 21, 2017 – Health Canada just communicated this important safety information: Cases of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) under treatment of patients with Pembrolizumab (Keytruda) have been reported internationally in the clinical trials and post-marketing setting. …
Risk of severe if not fatal skin reactions with Pembrolizumab (Keytruda) Read more »
October 12, 2016 – This is a communication from Health Canada, issued in May 2016, concerning the danger of reactivation of hepatitis B virus (HBV) infection in patients treated with BCR-ABL tyrosine kinase inhibitors (TKIs) and geared towards healthcare professionals (medical …
BCR-ABL Tyrosine Kinase Inhibitors: Danger of HBV-Reactivation Read more »
October 05, 2016 – Here, we make available to our readers a Drug Safety Communication by the American Food & Drug Administration (FDA), where FDA warns about the risk of hepatitis B virus (HBV) reactivation in some patients treated with …
September 01, 2016 – This is what we learned this morning and sadly, the issue of opioids use in the population along with its fatal outcomes seems never to stop. The American Food & Drug Asministation (FDA) requires, according to a …
The opioid epidemic: Is there a never ending sad story? Read more »